Clinical Trial Update: Safety and Efficacy Study of Xyrem® (Sodium Oxybate) in Subjects With Fibromyalgia. [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of Xyrem (sodium oxybate) in adults with fibromyalgia; the trial has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Xyrem (Sodium Oxybate)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED | Results posted: 2011-10-20